Selects Drexel Burnham Lambert to assist in the firm's financial restructuring. Based on a recent meeting between Revco, Drexel, senior preferred stock holders and bank lenders, the drug chain said it "feels confident that such parties will work with Revco and Drexel on the financial restructuring, which is aimed at making the company's debt payment schedules more consistent with the company's cash-generating capacity".
You may also be interested in...
The system has the potential to be the first FDA-cleared device for harvesting intact cancer cells from a blood sample for subsequent analysis.
Durable responses have continued to be seen two years after administration of Sarepta’s candidate gene therapy to four boys with Duchenne muscular dystrophy.
England’s health technology appraisal body, NICE, and the UK medicines regulator, the MHRA, are working together to align their process timelines so that access to medicines is “maintained and enhanced.”